ArticleBMC infectious diseases2023

COVID-19 monoclonal antibody treatment impact on symptoms and post-COVID conditions among high-risk patients at a Federally Qualified Health Center.

Natalie L Vawter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.